Generic Animal Drug Advancement Act
Official title: To amend the Federal Food, Drug, and Cosmetic Act to make certain changes with respect to the approval of abbreviated applications for the approval of new animal drugs, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Generic Animal Drug Advancement Act
This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 8857: Generic Animal Drug Advancement Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-8857/
"H.R. 8857: Generic Animal Drug Advancement Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-8857/.
H.R. 8857, 117th Cong. (2026), https://openamerica.io/bill/117-HR-8857/.
[H.R. 8857: Generic Animal Drug Advancement Act](https://openamerica.io/bill/117-HR-8857/)